Sensitivity and Specificity of an Electrocardiogram to Detect Echocardiographic Left Ventricular Hypertrophy in a Sample of 326 Tanzanian Adults: Differences in Men and Women

References

• Sundstrom J, Lind L, Arnlov J, Zethelius B, Andren B, Lithell HO. Echocardiographic and electrocardiographic diagnoses of left ventricular hypertrophy predict mortality independently of each other in a population of elderly men. Circulation. 2001;103(19):2346–2351. doi:10.1161/01.CIR.103.19.2346
   PubMed Web of Science ®Google Scholar
• Okwuosa TM, Soliman EZ, Lopez F, Williams KA, Alonso A, Ferdinand KC. Left ventricular hypertrophy and cardiovascular disease risk prediction and reclassification in blacks and whites: the Atherosclerosis Risk in Communities Study. Am Heart J. 2015;169(1):155–161 e155. doi:10.1016/j.ahj.2014.09.013
   PubMed Web of Science ®Google Scholar
• Bots ML, Nikitin Y, Salonen JT, et al. Left ventricular hypertrophy and risk of fatal and non-fatal stroke. EUROSTROKE: a collaborative study among research centres in Europe. J Epidemiol Community Health. 2002;56(Suppl 1):i8–13. doi:10.1136/jech.56.suppl_1.i8
   Google Scholar
• Tin LL, Beevers DG, Lip GY. Hypertension, left ventricular hypertrophy, and sudden death. Curr Cardiol Rep. 2002;4(6):449–457. doi:10.1007/s11886-002-0105-6
   PubMedGoogle Scholar
• Walker RW, Dewhurst M, Gray WK, et al. Electrocardiographic assessment of coronary artery disease and stroke risk factors in rural and urban Tanzania: a case-control study. J Stroke Cerebrovascular Dis. 2014;23(2):315–320.
   Web of Science ®Google Scholar
• Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2015;16(3):233–270.
   PubMed Web of Science ®Google Scholar
• Chillo P, Lwakatare J, Rieck AE, Lutale J, Gerdts E. Prevalence and covariates of abnormal left ventricular geometry in never-treated hypertensive patients in Tanzania. Blood Press. 2014;23(1):31–38. doi:10.3109/08037051.2013.791415
   PubMed Web of Science ®Google Scholar
• Chillo P, Lwakatare J, Lutale J, Gerdts E. Increased relative wall thickness is a marker of subclinical cardiac target-organ damage in African diabetic patients. Cardiovasc J Afr. 2012;23(8):435–441. doi:10.5830/CVJA-2012-023
   Web of Science ®Google Scholar
• Baldo MP, Goncalves MA, Capingana DP, Magalhaes P, da Silva ABT, Mill JG. Prevalence and Clinical Correlates of Left Ventricular Hypertrophy in Black Africans. High Blood Pressure Cardiovascular Prevent. 2018;25(3):283–289. doi:10.1007/s40292-018-0267-y
   Web of Science ®Google Scholar
• Ogah OS, Bamgboye AE. Correlates of left ventricular mass in hypertensive Nigerians: an echocardiographic study. Cardiovasc J Afr. 2010;21(2):79–85.
   Web of Science ®Google Scholar
• Tajeu GS, Safford MM, Howard G, et al. Black-White Differences in Cardiovascular Disease Mortality: a Prospective US Study, 2003–2017. Am J Public Health. 2020;110(5):696–703. doi:10.2105/AJPH.2019.305543
   Web of Science ®Google Scholar
• Yuyun MF, Sliwa K, Kengne AP, Mocumbi AO, Bukhman G. Cardiovascular Diseases in Sub-Saharan Africa Compared to High-Income Countries: an Epidemiological Perspective. Glob Heart. 2020;15(1):15. doi:10.5334/gh.403
   PubMed Web of Science ®Google Scholar
• Agabiti-Rosei E, Muiesan ML, Salvetti M. New approaches to the assessment of left ventricular hypertrophy. Ther Adv Cardiovasc Dis. 2007;1(2):119–128. doi:10.1177/1753944707086350
   Google Scholar
• Glezeva N, Gallagher J, Ledwidge M, et al. Heart failure in sub-Saharan Africa: review of the aetiology of heart failure and the role of point-of-care biomarker diagnostics. Tropical Med Int Health. 2015;20(5):581–588. doi:10.1111/tmi.12461
   Web of Science ®Google Scholar
• de Hartog-keyzer JML, El Messaoudi S, Harskamp R, et al. Electrocardiography for the detection of left ventricular hypertrophy in an elderly population with long-standing hypertension in primary care: a secondary analysis of the CHELLO cohort study. BMJ Open. 2020;10(8):e038824. doi:10.1136/bmjopen-2020-038824
   Web of Science ®Google Scholar
• Gasperin CA, Germiniani H, Facin CR, Souza AM, Cunha CL. An analysis of electrocardiographic criteria for determining left ventricular hypertrophy. Arq Bras Cardiol. 2002;78(1):59–82. doi:10.1590/S0066-782X2002000100006
   Google Scholar
• Goncalves MAA, Pedro JM, Silva C, Magalhaes P, Brito M. Normal limits of the electrocardiogram in Angolans. J Electrocardiol. 2020;63:68–74. doi:10.1016/j.jelectrocard.2020.10.011
   Web of Science ®Google Scholar
• Okin PM, Wright JT, Nieminen MS, et al. Ethnic differences in electrocardiographic criteria for left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint. Am J Hypertens. 2002;15(8):663–671. doi:10.1016/S0895-7061(02)02945-X
   Web of Science ®Google Scholar
• Mahn JJ, Dubey E, Brody A, et al. Test characteristics of electrocardiography for detection of left ventricular hypertrophy in asymptomatic emergency department patients with hypertension. Acad Emergency Med. 2014;21(9):996–1002. doi:10.1111/acem.12462
   Web of Science ®Google Scholar
• Petersen SS, Pedersen LR, Pareek M, et al. Factors associated with diagnostic discrepancy for left ventricular hypertrophy between electrocardiography and echocardiography. Blood Press. 2017;26(1):54–63. doi:10.1080/08037051.2016.1235959
   PubMed Web of Science ®Google Scholar
• Lutale JJ, Thordarson H, Gulam-Abbas Z, Vetvik K, Gerdts E. Prevalence and covariates of electrocardiographic left ventricular hypertrophy in diabetic patients in Tanzania. Cardiovasc J Afr. 2008;19(1):8–14.
   PubMed Web of Science ®Google Scholar
• Dzudie A, Choukem SP, Dehayem MY, Kengne AP. Blood pressure variables and prevalent electrocardiographic left ventricular hypertrophy in sub-Saharan African individuals with type 2 diabetes. J Diabetes. 2012;4(4):424–431. doi:10.1111/j.1753-0407.2012.00209.x
   Web of Science ®Google Scholar
• Huston SL, Bunker CH, Ukoli FA, Rautaharju PM, Kuller LH. Electrocardiographic left ventricular hypertrophy by five criteria among civil servants in Benin City, Nigeria: prevalence and correlates. Int J Cardiol. 1999;70(1):1–14. doi:10.1016/S0167-5273(99)00061-3
   Web of Science ®Google Scholar
• Dada A, Adebiyi AA, Aje A, Oladapo OO, Falase AO. Standard electrocardiographic criteria for left ventricular hypertrophy in Nigerian hypertensives. Ethn Dis. 2005;15(4):578–584.
   Web of Science ®Google Scholar
• Mbaye A, Dodo B, Ngaide AA, et al. Left ventricular hypertrophy in black African subjects with artery hypertension: results of a cross-sectional survey conducted in semi-rural area in Senegal. Ann de cardiologie et d’angeiologie. 2017;66(4):210–216. doi:10.1016/j.ancard.2017.04.011
   Google Scholar
• Jingi AM, Noubiap JJ, Kamdem P, Kingue S. Determinants and improvement of electrocardiographic diagnosis of left ventricular hypertrophy in a black African population. PLoS One. 2014;9(5):e96783. doi:10.1371/journal.pone.0096783
   Web of Science ®Google Scholar
• Robinson C, Woodiwiss AJ, Libhaber CD, Norton GR. Novel Approach to the Detection of Left Ventricular Hypertrophy Using Body Mass Index-Corrected Electrocardiographic Voltage Criteria in a Group of African Ancestry. Clin Cardiol. 2016;39(9):524–530. doi:10.1002/clc.22560
   Web of Science ®Google Scholar
• Chillo P, Rieck AE, Lwakatare J, Lutale J, Gerdts E. Left atrial volume index as a marker of left ventricular diastolic dysfunction in asymptomatic Tanzanian diabetic patients. Blood Press. 2013;22(2):86–93. doi:10.3109/08037051.2012.707351
   Web of Science ®Google Scholar
• National Institutes of Health. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. Obes Res. 1998;6(Suppl 2):51S–209S.
   PubMedGoogle Scholar
• Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Dahlof B. Baseline characteristics in relation to electrocardiographic left ventricular hypertrophy in hypertensive patients: the Losartan intervention for endpoint reduction (LIFE) in hypertension study. The Life Study Investigators. Hypertension. 2000;36(5):766–773. doi:10.1161/01.HYP.36.5.766
   PubMed Web of Science ®Google Scholar
• Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification. Eur J Echocardiogr. 2006;7(2):79–108. doi:10.1016/j.euje.2005.12.014
   PubMed Web of Science ®Google Scholar
• Devereux RB, Alonso DR, Lutas EM, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986;57(6):450–458. doi:10.1016/0002-9149(86)90771-X
   PubMed Web of Science ®Google Scholar
• Bang CN, Soliman EZ, Simpson LM, et al. Electrocardiographic Left Ventricular Hypertrophy Predicts Cardiovascular Morbidity and Mortality in Hypertensive Patients: the ALLHAT Study. Am J Hypertens. 2017;30(9):914–922. doi:10.1093/ajh/hpx067
   PubMed Web of Science ®Google Scholar
• Liao Y, Cooper RS, Durazo-Arvizu R, Mensah GA, Ghali JK. Prediction of mortality risk by different methods of indexation for left ventricular mass. J Am Coll Cardiol. 1997;29(3):641–647. doi:10.1016/S0735-1097(96)00552-9
   PubMed Web of Science ®Google Scholar
• Hancock EW, Deal BJ, Mirvis DM, et al. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part V: electrocardiogram changes associated with cardiac chamber hypertrophy: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society: endorsed by the International Society for Computerized Electrocardiology. Circulation. 2009;119(10):e251–261. doi:10.1161/CIRCULATIONAHA.108.191097
   Web of Science ®Google Scholar
• Okin PM, Roman MJ, Devereux RB, Kligfield P. Gender differences and the electrocardiogram in left ventricular hypertrophy. Hypertension. 1995;25(2):242–249. doi:10.1161/01.HYP.25.2.242
   PubMed Web of Science ®Google Scholar
• Levy D, Labib SB, Anderson KM, Christiansen JC, Kannel WB, Castelli WP. Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy. Circulation. 1990;81(3):815–820. doi:10.1161/01.CIR.81.3.815
   Web of Science ®Google Scholar
• Pewsner D, Juni P, Egger M, Battaglia M, Sundstrom J, Bachmann LM. Accuracy of electrocardiography in diagnosis of left ventricular hypertrophy in arterial hypertension: systematic review. BMJ. 2007;335(7622):711. doi:10.1136/bmj.39276.636354.AE
   PubMed Web of Science ®Google Scholar
• Okin PM, Hille DA, Kjeldsen SE, Devereux RB. Combining ECG Criteria for Left Ventricular Hypertrophy Improves Risk Prediction in Patients With Hypertension. J Am Heart Assoc. 2017;6(11). doi:10.1161/JAHA.117.007564
   Web of Science ®Google Scholar
• Mayosi BM, Avery PJ, Farrall M, Keavney B, Watkins H. Genome-wide linkage analysis of electrocardiographic and echocardiographic left ventricular hypertrophy in families with hypertension. Eur Heart J. 2008;29(4):525–530. doi:10.1093/eurheartj/ehn028
   Web of Science ®Google Scholar
• Colossimo AP, Costa Fde A, Riera AR, et al. Electrocardiogram sensitivity in left ventricular hypertrophy according to gender and cardiac mass. Arq Bras Cardiol. 2011;97(3):225–231. doi:10.1590/S0066-782X2011005000085
   Web of Science ®Google Scholar